<bill session="107" type="h" number="1574" updated="2013-07-14T18:57:35-04:00">
  <state datetime="2001-04-24">REFERRED</state>
  <status>
    <introduced datetime="2001-04-24"/>
  </status>
  <introduced datetime="2001-04-24"/>
  <titles>
    <title as="introduced" type="short">Pharmaceutical Products Price Equity Act</title>
    <title as="introduced" type="official">To provide for prices of pharmaceutical products that are fair to the producer and the consumer, and for other purposes.</title>
  </titles>
  <sponsor id="400306"/>
  <cosponsors/>
  <actions>
    <action state="REFERRED" datetime="2001-04-24">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2001-04-24">
      <text>Referred to House Energy and Commerce</text>
    </action>
    <action datetime="2001-04-24">
      <text>Referred to House Judiciary</text>
    </action>
    <action datetime="2001-05-04">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Energy and Commerce"/>
    </action>
    <action datetime="2001-09-28">
      <text>Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.</text>
      <committee name="House Judiciary"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
    <committee code="HSJU" name="House Judiciary" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSJU03" subcommittee="Courts, the Internet, and Intellectual Property" name="House Judiciary"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Actions and defenses"/>
    <term name="Administrative procedure"/>
    <term name="Administrative remedies"/>
    <term name="Class actions (Civil procedure)"/>
    <term name="Commerce"/>
    <term name="Crime and law enforcement"/>
    <term name="Damages"/>
    <term name="Drug industry"/>
    <term name="Economics and public finance"/>
    <term name="Fines (Penalties)"/>
    <term name="Government operations and politics"/>
    <term name="Injunctions"/>
    <term name="Law"/>
    <term name="Legal fees"/>
    <term name="Prescription pricing"/>
    <term name="Price discrimination"/>
    <term name="Price regulation"/>
    <term name="Punitive damages"/>
  </subjects>
  <amendments/>
  <summary>4/24/2001--Introduced.
Pharmaceutical Products Price Equity Act - Directs the President to issue orders and regulations, and establish procedures and reporting requirements to ensure that no pharmaceutical product is sold to any consumer in the United States at a price that is more than six percent above the average retail price at which such pharmaceutical product is sold in the five most industrialized, free-market countries, other than the United States. Sets forth enforcement and civil liability provisions.</summary>
</bill>
